Please assess the completion status of the following clinical trial:

Trial Title: Treximet Migraine Brain Imaging Research Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: None
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male or female (not pregnant or nursing)~* Age 18-65; with a focus on age 30-40 years~* Episodic migraine (experience migraine headache \<14 days out of the month), with focus on left-sided pain~* Currently taking Treximet routinely for migraine treatment~* No significant medical history (No illnesses such as seizure disorder, diabetes, alcoholism, cardiac disease including coronary artery disease, psychiatric problems; drug addiction, respiratory problems, liver disease, etc.)~* No significant medication history, except for migraine~* Weight, \<285 pounds~* Not claustrophobic~* No contraindication to taking triptans~Exclusion Criteria:~* Age \<18 or \> 65~* Significant medical problems (aside from pain before, during and after migraine episodes)~* Positive drug of abuse screen (excluding medications currently prescribed for their clinical condition, e.g. opioids, benzodiazepines, etc.)~* Use of opioid medications~* Claustrophobia~* History of dermatological hypersensitivity in the facial area~* Pregnancy~* Sensory loss detected on Quantitative Sensory Testing at screening~* Significant alcohol history (ingestion of 5 or more glasses (\> 40 oz) of alcohol per week)~* Metal implants of any type (including dental bridges, crowns, retainers, orthodontic devices e.g. braces, etc.)~* Tattoos containing metallic ink on the neck, shoulders, upper arm and head (which could become heated up in the scanner, and potentially cause blistering or burning)~* Cardiac pacemakers~* Aneurysm clips and other vascular stents, filters, clips or other devices~* Prosthetic heart valves~* Other prostheses~* Neuro-stimulator devices~* Implanted infusion pumps~* Cochlear (ear) implants~* Ocular (eye) implants or known metal fragments in eyes~* Exposure to shrapnel or metal filings (sheet metal workers, welders, and others)~* Other metallic surgical hardware in vital areas~* Any known allergic side effects to Treximet~* Use of any of the following medications:~* Monoamine Oxidase A- Inhibitors (Azilect, Eldepryl, Marplan, Nardil, Parnate, Zelapar)~* SSRI's: citalopram/ Celexa, Lepraxo, paroxetine/ Paxil, fluoxetine/ Prozac, Sarafem, Symbyax, Sertraline/ Zoloft, Fluvoxamine/ Luvox~* SNRI's: duloxetine/ Cymbalta, venlafaxine/ Effexor~* Triptans: sumatriptan/ Imitrex, naratriptan/ Amerge, zolmitriptan/ Zomig, rizatriptan/ Maxalt, eletriptan/ Relpax, almotriptan/ Axert~* Ergotamine type medicines: Bellergal, Cafergot, Ergomar, Wiraine, Migranal/ DHE45, Sansert

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Treximet (Type: None): All migraine subjects will receive Treximet during a migraine episode at Visit 2.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues